Thierry Thaure
Vorstandsvorsitzender bei GT Metabolic Solutions, Inc.
Profil
Thierry Bernard Thaure founded Cephea Valve Technologies, Inc. in 2012, where he worked as Chief Executive Officer from 2012 to 2019.
Mr. Thaure also currently works at GT Metabolic Solutions, Inc., as Chief Executive Officer & Director from 2021 and Aquyre Biosciences, Inc., as Director from 2019.
Mr. Thaure also formerly worked at EndoGastric Solutions, Inc., as President & Chief Executive Officer from 2010 to 2011, Mauna Kea Technologies, Inc., as Chief Executive Officer & Director from 2001 to 2012, TriFlo Cardiovascular, Inc., as President, Chief Executive Officer & Director from 2019 to 2021, Pulse Biosciences, Inc., as Independent Director from 2015 to 2017, FlexDex, Inc., as Director from 2019 to 2020, Origin Medsystems, Inc., as Director-International Business from 1995 to 1997, MedTech Acquisition Corp., as Director from 2021 to 2022, Guidant Corp., as Principal, Intuitive Surgical, Inc., as Vice President-Sales & Marketing from 1997 to 2001, and Accuray, Inc., as Senior Vice President-Sales & Marketing, GM from 2001 to 2004.
Mr. Thaure received his undergraduate degree from Duke University and Masters Business Admin degree from Kellogg School of Management.
Aktive Positionen von Thierry Thaure
| Unternehmen | Position | Beginn |
|---|---|---|
Aquyre Biosciences, Inc.
 Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | 01.01.2019 |
GT Metabolic Solutions, Inc.
 GT Metabolic Solutions, Inc. Medical SpecialtiesHealth Technology GT Metabolic Solutions, Inc. develops bypass technology for bariatric, metabolic, and digestive surgery. The company is based in San Jose, CA. Thierry Bernard Thaure has been the CEO of the company since 2020. | Vorstandsvorsitzender | 01.10.2021 |
Ehemalige bekannte Positionen von Thierry Thaure
| Unternehmen | Position | Ende |
|---|---|---|
TriFlo Cardiovascular, Inc.
 TriFlo Cardiovascular, Inc. Medical/Nursing ServicesHealth Services TriFlo Cardiovascular, Inc. operates as a biotechnology company. The company was founded in 2017 and is headquartered in Huntington Beach, CA. | Vorstandsvorsitzender | 01.10.2021 |
FlexDex, Inc.
 FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Direktor/Vorstandsmitglied | 01.01.2020 |
Cephea Valve Technologies, Inc.
 Cephea Valve Technologies, Inc. Medical/Nursing ServicesHealth Services Cephea Valve Technologies, Inc. provides medical devices. Its technology is being developed to provide an option for people whose diseased mitral valves need to be replaced. The artificial valve is designed to be delivered through a vein in the leg, forgoing the need for open-heart surgery. Replacement of the diseased mitral valve restores normal blood flow through the heart. The company was founded by Thierry Bernard Thaure and is headquartered in Santa Clara, CA. | Vorstandsvorsitzender | 01.01.2019 |
| PULSE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 02.11.2017 |
| Mauna Kea Technologies, Inc. | Vorstandsvorsitzender | 01.06.2012 |
Ausbildung von Thierry Thaure
| Duke University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ACCURAY INCORPORATED | Health Technology |
| INTUITIVE SURGICAL, INC. | Health Technology |
| PULSE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
EndoGastric Solutions, Inc.
 EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Health Technology |
Origin Medsystems, Inc.
 Origin Medsystems, Inc. Medical SpecialtiesHealth Technology Origin Medsystems, Inc., is a manufacturer of the products used in hernia repair surgery. This company is a subsidiary of Eli Lilly & Co. | Health Technology |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
Cephea Valve Technologies, Inc.
Cephea Valve Technologies, Inc. Medical/Nursing ServicesHealth Services Cephea Valve Technologies, Inc. provides medical devices. Its technology is being developed to provide an option for people whose diseased mitral valves need to be replaced. The artificial valve is designed to be delivered through a vein in the leg, forgoing the need for open-heart surgery. Replacement of the diseased mitral valve restores normal blood flow through the heart. The company was founded by Thierry Bernard Thaure and is headquartered in Santa Clara, CA. | Health Services |
| Mauna Kea Technologies, Inc. | |
TriFlo Cardiovascular, Inc.
TriFlo Cardiovascular, Inc. Medical/Nursing ServicesHealth Services TriFlo Cardiovascular, Inc. operates as a biotechnology company. The company was founded in 2017 and is headquartered in Huntington Beach, CA. | Health Services |
MedTech Acquisition Corp.
 MedTech Acquisition Corp. Financial ConglomeratesFinance MedTech Acquisition Corp. is a blank check company, which engages in the business of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It also focuses on operating in the healthcare sector. The company was founded on September 11, 2020 and is headquartered in Greenwich, CT. | Finance |
FlexDex, Inc.
FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Health Technology |
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
GT Metabolic Solutions, Inc.
GT Metabolic Solutions, Inc. Medical SpecialtiesHealth Technology GT Metabolic Solutions, Inc. develops bypass technology for bariatric, metabolic, and digestive surgery. The company is based in San Jose, CA. Thierry Bernard Thaure has been the CEO of the company since 2020. | Health Technology |
